Question 1

Am I eligible to participate in this trial based on my current condition?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Chloroquine Diphosphate for the Treatment of Severe Acute Respiratory Syndrome Secondary to SARS-CoV2 clinical trial (NCT04323527). Contact the study team or your healthcare provider for specific answers.

Question 2

What are the potential benefits and risks of taking chloroquine diphosphate?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Chloroquine Diphosphate for the Treatment of Severe Acute Respiratory Syndrome Secondary to SARS-CoV2 clinical trial (NCT04323527). Contact the study team or your healthcare provider for specific answers.

Question 3

How does this treatment compare to other options available for my condition?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Chloroquine Diphosphate for the Treatment of Severe Acute Respiratory Syndrome Secondary to SARS-CoV2 clinical trial (NCT04323527). Contact the study team or your healthcare provider for specific answers.

Question 4

What kind of monitoring will I receive during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Chloroquine Diphosphate for the Treatment of Severe Acute Respiratory Syndrome Secondary to SARS-CoV2 clinical trial (NCT04323527). Contact the study team or your healthcare provider for specific answers.

Question 5

How long will I need to participate in the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Chloroquine Diphosphate for the Treatment of Severe Acute Respiratory Syndrome Secondary to SARS-CoV2 clinical trial (NCT04323527). Contact the study team or your healthcare provider for specific answers.

Question 6

What should I expect in terms of side effects?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Chloroquine Diphosphate for the Treatment of Severe Acute Respiratory Syndrome Secondary to SARS-CoV2 clinical trial (NCT04323527). Contact the study team or your healthcare provider for specific answers.

What this study is about